| 今开：0.327 | 昨收：0.3271 |
| 最高：0.3273 | 最低：0.2902 |
| 涨停价：0.0 | 跌停价：0.0 |
| 总市值：4064499.0 |
产业链观察03-20 00:37
#药闻简讯# $Seelos Therapeutics(SEEL)$ SLS-005（静脉注射海藻糖）的肌萎缩侧索硬化症 （ALS） 研究 - 在主要和次要终点中未达到统计学意义。#临床研究失败#查看全文
Seelos Therapeutics(SEEL)02-02 19:15
$Seelos Therapeutics(SEEL)$ S-1 General form for registration of securities under the Securities Act of 1933 Accession Number: 0001104659-24-009647 Act: 33 Size: 746 KB 网页链接查看全文
Seelos Therapeutics(SEEL)03-07 08:45
$Seelos Therapeutics(SEEL)$ S-1/A [Amend] General form for registration of securities under the Securities Act of 1933 Accession Number: 0001104659-24-031555 Act: 33 Size: 803 KB 网页链接查看全文
Seelos Therapeutics(SEEL)03-18 18:15
$Seelos Therapeutics(SEEL)$ EFFECT Notice of Effectiveness Accession Number: 9999999995-24-000670 Act: 33 Size: 1 KB 网页链接查看全文
Seelos Therapeutics(SEEL)03-16 04:25
$Seelos Therapeutics(SEEL)$ 424B3 Prospectus [Rule 424(b)(3)] Accession Number: 0001104659-24-035009 Act: 33 Size: 574 KB 网页链接查看全文
Seelos Therapeutics(SEEL)03-28 20:05
$Seelos Therapeutics(SEEL)$ 8-K Current report, items 1.01 and 9.01 Accession Number: 0001104659-24-040106 Act: 34 Size: 226 KB 网页链接查看全文
Seelos Therapeutics(SEEL)01-30 19:15
$Seelos Therapeutics(SEEL)$ 424B5 Prospectus [Rule 424(b)(5)] Accession Number: 0001104659-24-007935 Act: 33 Size: 786 KB 网页链接查看全文
Seelos Therapeutics(SEEL)03-02 06:45
$Seelos Therapeutics(SEEL)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001104659-24-030070 Size: 5 KB 网页链接查看全文
Seelos Therapeutics(SEEL)03-07 19:05
$Seelos Therapeutics(SEEL)$ S-8 Securities to be offered to employees in employee benefit plans Accession Number: 0001104659-24-031558 Act: 33 Size: 102 KB 网页链接查看全文
Seelos Therapeutics(SEEL)02-07 06:35
$Seelos Therapeutics(SEEL)$ SC 13G Statement of acquisition of beneficial ownership by individuals Accession Number: 0000929638-24-000387 Act: 34 Size: 81 KB 网页链接查看全文
Seelos Therapeutics盘前跌4.25%，报0.153美元。消息上，在Seelos Therapeutics公布了SLS-002治疗抑郁症的2期临床试验数据后，Cantor Fitzgerald将该公司的评级从“增持”下调至“中性”，同时没有... 网页链接
$Seelos Therapeutics(SEEL)$ 8-K Current report, items 1.01 and 9.01 Accession Number: 0001104659-24-040106 Act: 34 Size: 226 KB 网页链接
$Seelos Therapeutics(SEEL)$ 8-K Current report, items 8.01 and 9.01 Accession Number: 0001104659-24-036125 Act: 34 Size: 2 MB 网页链接
$Seelos Therapeutics(SEEL)$ EFFECT Notice of Effectiveness Accession Number: 9999999995-24-000670 Act: 33 Size: 1 KB 网页链接
$Seelos Therapeutics(SEEL)$ 424B3 Prospectus [Rule 424(b)(3)] Accession Number: 0001104659-24-035009 Act: 33 Size: 574 KB 网页链接
$Seelos Therapeutics(SEEL)$ S-8 Securities to be offered to employees in employee benefit plans Accession Number: 0001104659-24-031558 Act: 33 Size: 102 KB 网页链接
$Seelos Therapeutics(SEEL)$ S-1/A [Amend] General form for registration of securities under the Securities Act of 1933 Accession Number: 0001104659-24-031555 Act: 33 Size: 803 KB 网页链接
$Seelos Therapeutics(SEEL)$ 10-K Annual report [Section 13 and 15(d), not S-K Item 405] Accession Number: 0001410578-24-000140 Act: 34 Size: 9 MB 网页链接
$Seelos Therapeutics(SEEL)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001104659-24-030070 Size: 5 KB 网页链接
$Seelos Therapeutics(SEEL)$ D Notice of Exempt Offering of Securities, item 06b Accession Number: 0001104659-24-023870 Act: 33 Size: 11 KB 网页链接
$Seelos Therapeutics(SEEL)$ SC 13G Statement of acquisition of beneficial ownership by individuals Accession Number: 0000929638-24-000387 Act: 34 Size: 81 KB 网页链接